Trial Profile
Metabolic effects of antipsychotics in children.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2018
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Olanzapine (Primary) ; Risperidone (Primary)
- Indications Behavioural disorders; Psychotic disorders
- Focus Pharmacodynamics
- Acronyms MEAC
- 02 Aug 2011 Additional lead trial investigator (Ginger Nicol) identified as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.